Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
207.68
+1.04 (0.50%)
At close: Oct 5, 2026, 4:00 PM EDT
207.52
-0.16 (-0.08%)
Pre-market: Oct 6, 2026, 7:40 AM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $44.51 billion as of October 5, 2026. Its market cap has increased by 409.79% in one year.
Market Cap
44.51B
Enterprise Value
41.77B
1-Year Change
409.79%
Ranking
Category
Stock Price
$207.68
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $44.51B, an increase of 2,606.84%. That is a compound annual growth rate of 64.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 44.51B | 189.09% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moderna | 75.86B |
| Regeneron Pharmaceuticals | 73.41B |
| argenx SE | 57.39B |
| BeOne Medicines AG | 40.71B |
| Royalty Pharma | 32.87B |
| Alnylam Pharmaceuticals | 29.40B |
| Roivant Sciences | 25.80B |
| BioNTech SE | 24.34B |